Cardiovascular Systems (CSII) Tops Q4 EPS by 5c; Offers Q1 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Needham & Company Raises Price Target on Cardiovascular Systems (CSII) to $27 Following 4Q Beat
August 4, 2016 8:14 AM EDTNeedham & Company reiterated a Buy rating on Cardiovascular Systems (NASDAQ: CSII), and raised the price target to $27.00 (from $23.00), following the company's 4Q earnings report. Revenue was $48.5M vs. consensus of $46.0M and GAAP EPS was ($0.15) vs. consensus of ($0.20).
Analyst Mike Matson... More
BofA/Merrill Lynch Upgrades Cardiovascular Systems (CSII) to Neutral
August 4, 2016 6:51 AM EDTBofA/Merrill Lynch upgraded Cardiovascular Systems (NASDAQ: CSII) from Underperform to Neutral.
For an analyst ratings summary and ratings history on Cardiovascular Systems click here. For more ratings news on Cardiovascular Systems click here.
Shares of Cardiovascular Systems closed at $19.74 yesterday.
... More